VMI
GBT

VHCP Management II’s Global Blood Therapeutics, Inc. GBT Stock Holding History

VHCP Management II’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-170,312
Closed -$2.83M – 25
2016
Q2 		$2.83M Hold
170,312
– – 1.71% 16
2016
Q1 		$2.7M Buy
170,312
+28,701
+20% +$510K 1.78% 18
2015
Q4 		$4.58M Buy
+141,611
New +$6.13M 3.76% 11

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

VHCP Management II's GBT Position: Q3 2016 in Review

VHCP Management II sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2016, closing a stake of 170,312 shares — an estimated $2.83M sold.

VHCP Management II first reported a position in GBT in Q4 2015 and held it in 3 quarters. The position peaked at $4.58M in Q4 2015. 84 funds tracked by Wall St. Rank hold GBT as of Q3 2016.

  • VHCP Management II reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
  • VHCP Management II sold 170,312 Global Blood Therapeutics, Inc. shares in Q3 2016, an estimated $2.83M.
  • VHCP Management II first reported a position in Global Blood Therapeutics, Inc. in Q4 2015 and held it in 3 quarters.
  • VHCP Management II's Global Blood Therapeutics, Inc. position peaked at $4.58M in Q4 2015.
  • 84 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2016.

Based on VHCP Management II's 13F filing for Q3 2016, filed 14 Nov 2016.